Skip to Content
Merck

Human RECQL1 participates in telomere maintenance.

Nucleic acids research (2014-03-14)
Venkateswarlu Popuri, Joseph Hsu, Prabhat Khadka, Kent Horvath, Yie Liu, Deborah L Croteau, Vilhelm A Bohr
ABSTRACT

A variety of human tumors employ alternative and recombination-mediated lengthening for telomere maintenance (ALT). Human RecQ helicases, such as BLM and WRN, can efficiently unwind alternate/secondary structures during telomere replication and/or recombination. Here, we report a novel role for RECQL1, the most abundant human RecQ helicase but functionally least studied, in telomere maintenance. RECQL1 associates with telomeres in ALT cells and actively resolves telomeric D-loops and Holliday junction substrates. RECQL1 physically and functionally interacts with telomere repeat-binding factor 2 that in turn regulates its helicase activity on telomeric substrates. The telomeric single-stranded binding protein, protection of telomeres 1 efficiently stimulates RECQL1 on telomeric substrates containing thymine glycol, a replicative blocking lesion. Loss of RECQL1 results in dysfunctional telomeres, telomere loss and telomere shortening, elevation of telomere sister-chromatid exchanges and increased aphidicolin-induced telomere fragility, indicating a role for RECQL1 in telomere maintenance. Further, our results indicate that RECQL1 may participate in the same pathway as WRN, probably in telomere replication.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Hydroxyurea, 98%, powder
Sigma-Aldrich
DAPI, for nucleic acid staining
Sigma-Aldrich
MISSION® esiRNA, targeting human TERF2
Hydroxycarbamide, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Recql
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Wrn
Sigma-Aldrich
MISSION® esiRNA, targeting human RECQL
Sigma-Aldrich
MISSION® esiRNA, targeting human WRN
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Terf2
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Tbpl1
Sigma-Aldrich
MISSION® esiRNA, targeting human TBPL1